RxDoctor Payments Data

Venkataraman Muthusamy, MD

Gastroenterology · Los Angeles, CANPI 1790865954

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 70.6% of it on its own, with 19 other manufacturers making up the rest. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$297,394in general payments, 2019–2025

Across 416 payments — averaging $714.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$210K
  • Olympus Corporation$18K
  • Merit Medical Systems Inc$16K
  • Endogastric Solutions, Inc$14K
  • Medtronic$13K
  • Covidien LP$12K
  • plus $16K from 14 others
$224,384in research payments, 2019–2025

Across 24 payments — averaging $9349.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$221K
  • Medtronic$2K
  • Covidien LP$1K
$174,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $24,857 each. An ownership or investment interest held by the physician or an immediate family member.

  • Capsovision, Inc.$174K

What the payments were for

  • Consulting fees$79,36527%
  • Speaking & faculty fees$173,19258%
  • Grants$5000%
  • Travel & lodging$24,9308%
  • Food & beverage$19,4077%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$297,394 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California

Medicare billing

Part B allowed, 2024
$134,932
Medicare patients
403
Services billed
885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate14$3,151
Omeprazole56$690
Pantoprazole Sodium19$355
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl16$301

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →